Author:
Grandvuillemin Aurélie,Rocher Fanny,Valnet-Rabier Marie Blanche,Drici Milou-Daniel,Dautriche Anne
Reference20 articles.
1. HCSP. Avis relatif à la prise en charge des cas confirmés d’infection au virus SARS-CoV2. 5 mars 2020. https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=771.[Accessed 9 January 2023].
2. French pharmacovigilance Network. French pharmacovigilance Network. French pharmacovigilance public system and COVID-19 pandemic;Grandvuillemin;Drug Saf,2021
3. ANSM. Suivi des effets indésirables des médicaments utilisés dans la prise en charge du COVID-19. 2022. http://ansm.sante.fr/dossiers-thematiques/covid-19-dispositif-renforce-de-pharmacovigilance-et-daddictovigilance. [Accessed 9 January 2023].
4. Causality assessment in pharmacovigilance: the French method and its successive updates;Miremont-Salamé;Therapie,2016
5. Pharmacovigilance and drug safety: fair prescribing and clinical research;Montastruc;Therapie,2022
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献